Details of the Drug

General Information of Drug (ID: DMDAKZW)

Drug Name

Vacc-4x

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus-1 infection	1C62	Phase 2	[1]

Drug Type

Vaccine

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Human immunodeficiency virus Capsid p24 (HIV p24)	TTTWS2G	POL_HV1B1	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01712256) Re-boosting of HIV-1 Infected Subjects With Vacc-4x. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Bionor Pharma.
3	Clinical pipeline report, company report or official report of Gilead Sciences.
4	EP patent application no. 2621528, Vaccine.